← Back to Search

Corticosteroid

Dexamethasone for Eye Disorders

Phase 3
Recruiting
Led By Oculis Investigative Site
Research Sponsored by Oculis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 15
Awards & highlights

Study Summary

This trial will compare the effectiveness and safety of a new eye drop to a placebo in treating inflammation and pain after cataract surgery.

Eligible Conditions
  • Post-Cataract Surgery Eye Disorders

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 15
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 15 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With an Absence of Anterior Chamber Inflammation
Eye pain

Side effects data

From 2013 Phase 4 trial • 122 Patients • NCT01474915
2%
Cerebrospinal fluid leak
2%
Deep Vein Thrombosis
2%
Fever
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ondansetron
Aprepitant

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active Treatment ArmExperimental Treatment1 Intervention
OCS-01 (Ophthalmic Suspension) - topical use
Group II: Vehicle Placebo ArmPlacebo Group1 Intervention
Vehicle
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexamethasone
2007
Completed Phase 4
~2590

Find a Location

Who is running the clinical trial?

OculisLead Sponsor
8 Previous Clinical Trials
1,490 Total Patients Enrolled
Oculis Investigative SitePrincipal InvestigatorStudy Principal Investigator
1 Previous Clinical Trials
497 Total Patients Enrolled
~82 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top